Persistent Pursuit in Research of Artemisinin: Fast Elimination of Malaria Commemoration for the 50th Anniversary of Project 523
10.13359/j.cnki.gzxbtcm.2017.03.001
- VernacularTitle:青蒿素抗疟研究的不断追求:快速消灭疟疾——纪念执行“523”任务50周年
- Author:
Guoqiao LI
;
Xingbo GUO
;
Linchun FU
- Keywords:
artemisinin;
artemisinin-based combinations (ACTs);
Fast Elimination of Malaria by Source Eradication(FEMSE);
malaria;
Guangzhou University of Chinese Medicine
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2017;34(3):303-307
- CountryChina
- Language:Chinese
-
Abstract:
At the 50th Anniversary of Project 523,we reviewed the course and progress made by the Artemisinin Anti-malaria Research Group of Guangzhou University of Chinese Medicine in the application of artemisinin for treating malaria.As one of the groups participating in the mission of Project 523,Artemisinin Anti-malaria Research Group of Guangzhou University of Chinese Medicine was in charge of the clinical trials in treating malaria with artemisinin and its derivatives of various preparation forms,dosages and treatment courses(years 1974-1989),developed the artemisinin-based combinations(ACTs) Artekin and Artequick for malaria treatment and performed their clinical trials(years 1984-2006).For the recent 10 years,the group has been devoted in the implementation of anti-malaria programme FEMSE (Fast Elimination of Malaria by Source Eradication) in south-east Asia and Africa.The scientific explorations and achievements of this research group have made great contribution in bringing artemisinins to the world and creating a simple,practical and cost-effective new method for rapid global malaria elimination.
